Overview

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the impact of Zometa on clearance of bone marrow micrometastases; the protective effect on chemotherapy-induced loss of bone mineral density; and quality of life in women undergoing treatment for locally advanced breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
Novartis
Pfizer
Treatments:
Docetaxel
Epirubicin
Trastuzumab
Zoledronic Acid